Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taspoglutide Titration Study in T2DM Patients on Metformin
NCT00460941Phase 2Completed
- Sponsor
- Roche
- Start
- Apr 2007
- Primary completion
- Jan 2008
- Modality
- Peptides
- Countries
- 7
01
Overview
A Phase 2 trial of taspoglutide in type 2 diabetes mellitus (T2DM), sponsored by Roche. Started Apr 2007; status: completed.
02
Drugs
taspoglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00460941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00460941.